Table 2 |
||||
| Frequency of β1 integrin (β1), Progesterone Receptor (PR) and Estrogen Receptor (ER) expression in breast carcinomas | ||||
| Markers | Group | P-value | ||
| IDC | DCIS | |||
| n (%) | n (%) | |||
| β1 | Negative | 151 (67,1) | 45 (67,2) | 1.000a |
| Positive | 74 (32,9) | 22 (32,8) | ||
| PR | Negative | 87 (38,7) | 20 (29,9) | 0.198a |
| Positive | 138 (61,3) | 47 (70,1) | ||
| ER | Negative | 76 (33,8) | 17 (25,4) | 0.233a |
| Positive | 149 (66,2) | 50 (74,6) | ||
dos Santos et al. Diagnostic Pathology 2012 7:104 doi:10.1186/1746-1596-7-104
